RXL:NYE-ProShares Ultra Health Care (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 44.79

Change

+0.78 (+1.77)%

Market Cap

N/A

Volume

3.60K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-30 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B..

+0.30 (+2.53%)

USD 8.14B
QLD ProShares Ultra QQQ

-0.02 (-0.02%)

USD 5.50B
SSO ProShares Ultra S&P500

+0.02 (+0.03%)

USD 4.33B
FNGU MicroSectors FANG+ Index 3X Le..

N/A

USD 4.29B
UPRO ProShares UltraPro S&P500

+0.07 (+0.10%)

USD 2.91B
TECL Direxion Daily Technology Bull..

+0.72 (+1.32%)

USD 1.95B
YINN Direxion Daily FTSE China Bull..

+0.04 (+0.12%)

USD 1.19B
USD ProShares Ultra Semiconductors

+0.08 (+0.21%)

USD 0.61B
UDOW ProShares UltraPro Dow30

+0.59 (+0.79%)

USD 0.56B
LABU Direxion Daily S&P Biotech Bul..

+2.42 (+4.16%)

USD 0.53B

ETFs Containing RXL

KGHG 4.13 % 0.00 %

N/A

N/A
IEUS iShares MSCI Europe Small.. 0.00 % 0.40 %

+0.13 (+0%)

USD 0.10B
SCZ iShares MSCI EAFE Small-C.. 0.00 % 0.39 %

-0.18 (0%)

USD 9.36B
LGWU:F Lyxor Index Fund - Lyxor .. 0.00 % 0.00 %

N/A

N/A
ZPRX:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

+0.29 (+0%)

USD 0.21B
ZPRX:XETRA SPDR® MSCI Europe Small .. 0.00 % 0.00 %

+0.51 (+0%)

N/A
1388:TSE 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.82% 69% C- 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.82% 69% C- 71% C-
Trailing 12 Months  
Capital Gain -6.02% 43% F 29% F
Dividend Return 1.26% 77% C+ 25% F
Total Return -4.76% 43% F 25% F
Trailing 5 Years  
Capital Gain 64.06% 40% F 63% D
Dividend Return 4.62% 31% F 9% A-
Total Return 68.68% 36% F 54% F
Average Annual (5 Year Horizon)  
Capital Gain 8.04% 31% F 64% D
Dividend Return 8.43% 28% F 58% F
Total Return 0.39% 23% F 10% F
Risk Return Profile  
Volatility (Standard Deviation) 28.88% 97% N/A 34% F
Risk Adjusted Return 29.19% 50% F 46% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.